“Thumb's off” for acrometastasis of renal cell carcinoma: Is there a role for acrometastasectomy in the era of targeted therapy?

Asian Journal of Urology, 2018, 5 (3): 199-201 doi: 10.1016/j.ajur.2017.07.003

Letter

Current Issue | Archive | Adv Search

|

“Thumb's off” for acrometastasis of renal cell carcinoma: Is there a role for acrometastasectomy in the era of targeted therapy?

Sivaneswaran Lechmiannandan(

),Nurbaiti Aida

Urology Unit, Department of General Surgery, Queen Elizabeth Hospital, Kota Kinabalu, Sabah, Malaysia

Abstract
Related Citation (0)

[1]	J.H. Healey, A.D. Turnbull, B. Miedema, J.M. Lane . Acrometastases. A study of twenty-nine patients with osseous involvement of the hands and feet.J Bone Jt Surg Am, 68(1986), pp. 743-746 doi: 10.2106/00004623-198668050-00017 pmid: 3459730
[2]	M.A. Ghert, J.M. Harrelson, S.P. Scully . Solitary renal cell carcinoma metastasis to the hand: the need for wide excision or amputation.J Hand Surg, 26A(2001), pp. 156-160 doi: 10.1053/jhsu.2001.20163 pmid: 11172383
[3]	C.J. Flynn, C. Danjoux, J. Wong, M. Christakis, J. Rubenstein, A. Yee , et al.Two cases of acrometastasis to the hands and review of the literature.Curr Oncol, 15(2008), pp. 51-58 doi: 10.3747/co.v15i5.189 pmid: 19008991
[4]	G. Maccauro, M. Esposito, F. Muratori, C. Gebert, G. Gosheger, C.A. Logroscino . A report of a very rare localization of bone metastasis to the talus.Eur J Orthop Surg Trauma, 16(2006), pp. 67-69 doi: 10.1007/s00590-005-0019-2
[5]	D. Stomeo, A. Tulli, A. Ziranu, C. Perisano, S. Maccauro Vde . Acrometastasis: a literature review.Eur Rev Med Pharmacol Sci, 19(2015), pp. 2906-2915 pmid: 26241547
[6]	J. Syrios, G. Kechagias, N. Tsavaris . Prolonged survival after sequential multimodal treatment in metastatic renal cell carcinoma: two case reports and a review of the literature.J Med Case Rep, 6(2012), p. 303 doi: 10.1186/1752-1947-6-303 pmid: 3459787
[7]	F. Chen, T. Fujinaga, T. Shoji, R. Miyahara, T. Bando, K. Okubo , et al.Pulmonary resection for metastasis from renal cell carcinoma.Interact Cardiovasc Thorac Surg, 7(2008), pp. 825-828 doi: 10.1510/icvts.2008.181065
[8]	S. Weikert, C. Kempkensteffen, J. Busch, M. Johannsen, V. Grünwald, K. Zimmermann , et al.Sequential mTOR inhibitor treatment with temsirolimus in metastatic renal cell carcinoma following failure of VEGF receptor tyrosine kinase inhibitors.World J Urol, 31(2013), pp. 805-809 doi: 10.1007/s00345-011-0676-1 pmid: 21512806
[9]	R.J. Motzer, B. Escudier, P. Tomczak, T.E. Hutson, M.D. Michaelson, S. Negrier , et al.Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial.Lancet Oncol, 14(2013), pp. 552-562 doi: 10.1016/S1470-2045(13)70093-7 pmid: 23598172
[10]	A.F. Mavrogenis, G. Mimidis, Z.T. Kokkalis, E.S. Karampi, I. Karampela, P.J. Papagelopoulos , et al.Acrometastases.Eur J Orthop Surg Traumatol, 24(2014), pp. 279-283 doi: 10.1007/s00590-013-1311-1
[11]	C.S. Hsu, V.R. Hentz, J. Yao . Tumours of the hand.Lancet Oncol, 8(2007), pp. 157-166 doi: 10.1016/S1470-2045(07)70035-9